Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 2.531
-0.080 (-3.06%)
Oct 2, 2026, 5:35 PM CET
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €480 million as of October 2, 2026. Its market cap has decreased by -45.09% in one year.
Market Cap
480.00M
Enterprise Value
568.70M
Revenue
142.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.53
ChartMarket Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 480.00M, an increase of 384.46%. That is a compound annual growth rate of 8.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 480.00M | -25.27% |
| Dec 31, 2025 | 642.32M | 82.94% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.40B |
| MedinCell | 832.43M |
| Inventiva | 778.54M |
| DBV Technologies | 579.99M |
| Genfit | 472.23M |
| Valerio Therapeutics Société anonyme | 265.21M |
| Transgene | 197.74M |
| Innate Pharma | 131.37M |